Total Payments
$12,349
2024 Payments
$1,729
Companies
28
Transactions
409
Medicare Patients
14,707
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$12,271 (99.4%)
Education$78.39 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,271 | 401 | 99.4% |
| Education | $78.39 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,121 | 41 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,856 | 46 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,521 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,297 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,018 | 58 | $0 (2024) |
| PFIZER INC. | $585.64 | 35 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $566.06 | 12 | $0 (2022) |
| Merck Sharp & Dohme LLC | $563.63 | 29 | $0 (2024) |
| CVRx, Inc. | $375.21 | 5 | $0 (2022) |
| Boston Scientific Corporation | $348.01 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,729 | 54 | Teva Pharmaceuticals USA, Inc. ($250.01) |
| 2023 | $1,434 | 59 | AstraZeneca Pharmaceuticals LP ($442.12) |
| 2022 | $1,557 | 54 | CVRx, Inc. ($375.21) |
| 2021 | $1,247 | 59 | AstraZeneca Pharmaceuticals LP ($310.34) |
| 2020 | $681.61 | 29 | PFIZER INC. ($180.08) |
| 2019 | $1,791 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($642.75) |
| 2018 | $2,247 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,113) |
| 2017 | $1,663 | 48 | Novartis Pharmaceuticals Corporation ($351.84) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.47 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $109.54 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.12 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $39.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 8,725 | 21,440 | $9.5M | $854,785 |
| 2022 | 24 | 3,185 | 8,148 | $3.8M | $415,512 |
| 2021 | 20 | 1,634 | 3,976 | $1.3M | $312,642 |
| 2020 | 15 | 1,163 | 2,386 | $542,404 | $200,266 |
Total Patients
14,707
Total Services
35,950
Medicare Billing
$1.8M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 1,620 | 6,713 | $3.8M | $277,172 | 7.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 1,523 | 6,364 | $4.6M | $271,054 | 5.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 690 | 692 | $214,741 | $73,146 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 348 | $105,240 | $35,277 | 33.5% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 690 | 692 | $103,800 | $31,386 | 30.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,054 | 3,869 | $77,380 | $28,215 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 376 | $82,300 | $27,123 | 33.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 438 | 447 | $84,930 | $26,705 | 31.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 105 | 108 | $62,250 | $19,430 | 31.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 249 | 484 | $273,644 | $16,877 | 6.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 83 | 88 | $32,977 | $10,294 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $18,675 | $6,645 | 35.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 100 | $15,000 | $4,875 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 222 | 400 | $16,000 | $4,859 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $15,280 | $4,535 | 29.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 35 | $11,890 | $3,685 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $7,290 | $2,661 | 36.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $7,050 | $2,631 | 37.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 25 | 25 | $3,000 | $1,895 | 63.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 236 | 244 | $4,880 | $1,766 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 171 | $1,710 | $1,436 | 84.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 69 | 69 | $3,450 | $1,109 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,400 | $1,007 | 72.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 21 | 21 | $1,470 | $433.01 | 29.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 28 | 28 | $1,120 | $306.43 | 27.4% |
About Dr. Chaim Gitelis, D.O
Dr. Chaim Gitelis, D.O is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508086109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chaim Gitelis, D.O has received a total of $12,349 in payments from pharmaceutical and medical device companies, with $1,729 received in 2024. These payments were reported across 409 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($12,271).
As a Medicare-enrolled provider, Gitelis has provided services to 14,707 Medicare beneficiaries, totaling 35,950 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 04/26/2007
- Last Updated 12/09/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508086109
Products in Payments
- ELIQUIS (Drug) $1,857
- JARDIANCE (Drug) $1,551
- XARELTO (Drug) $1,297
- FARXIGA (Drug) $1,251
- ENTRESTO (Drug) $686.39
- LifeVest (Device) $566.06
- BRILINTA (Drug) $508.65
- VERQUVO (Drug) $427.31
- Barostim Neo System (Device) $375.21
- PRADAXA (Drug) $338.45
- LEQVIO (Drug) $332.01
- WATCHMAN (Device) $281.13
- MULTAQ (Drug) $251.66
- Austedo XR (Drug) $250.01
- Ozempic (Drug) $212.93
- CAMZYOS (Drug) $195.26
- MOUNJARO (Drug) $188.64
- HeartMate 3 Left Ventricular Dev (Device) $176.37
- MONOFERRIC (Drug) $150.00
- ZINPLAVA (Biological) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733